L’électrospinning est un procédé couramment utilisé pour la fabrication de membranes nanofibreuses non-tissées. Ces membranes sont particulièrement intéressantes pour des applications tels que l’ingénierie tissulaire et la libération contrôlée de médicaments car elles sont très poreuses et ont une large surface spécifique. Dans une première partie, nous avons développé une nouvelle stratégie afin de contrôler la morphologie et la dimension des fibres fabriquées par electrospinning. Puis nous avons développé un composite fait de nanofibres de PLA et de microparticules de PEG auto-organisé, créant des motifs en nid d’abeilles qui grandissent avec l’épaisseur de la membrane. Ces membranes auto-organisées ont une structure poreuse dont la dimension des pores va de quelques microns à plusieurs centaines de microns. Enfin, deux modèles ont été développés pour une libération contrôlée d’un composé model : la délivrance retardée par l’élaboration de structure sandwich et la libération directionnnelle par la création d’un gradient de concentration avec différentes cinétiques. / Electrospinning is widely used for the synthesis of nanofibrous non-woven membranes. The fabricated electrospun membranes have high porosity and high surface to volume ratio; they are thus suitable for many applications such as sensing, tissue engineering or drug delivery. In the present work, the first focus was on the fabrication of electrospun fibers with controlled morphology and dimension. Then A self-organized honeycomb-like composite made of simultaneously electrosprayed PEG microparticles and PLA electrospun fibers was developed. The obtained composite mat exhibits a hierarchical, porous structure with pore sizes ranging from few microns up to several hundreds of microns. Finally, a method tailoring the hydrophobicity of drug loaded nanofibrous membranes by the incorporation of electrosprayed PEG microparticles was developed.

The Electrospray (ES) technique is a promising particle generation method for drug delivery due to its capabilities of producing monodisperse PLGA composite particles with unique configurations and high drug encapsulation efficiency. In the dissertation work, the coaxial dual capillary ES was used to generate drug-loaded core-shell PLGA particles to study the effects of particle filling materials, drug loading locations and particle shell thicknesses on the resultant in vitro release behaviors of the hydrophilic and/ or hydrophobic model drugs. Through release profile characterization of drug-loaded PLGA particles (particle size: 400 nm and 1 μm), it was confirmed that the co-encapsulation of Budesonide (BUD, the hydrophobic small-molecule model drug) and Theophylline (THY, the hydrophilic small-molecule model drug) in the particle cores is the most effective drug loading strategy for extended release of the fixed combined BUD and THY. Particles composed of PLGA fillers with lower molecular weights and with greater shell layer thicknesses could release THY in a well controlled fashion. On the other hand, a slower release rate of Bovine Serum Albumin (BSA, the protein model drug) from PLGA particles with greater shell thickness was also observed. Sequential release of BSA and Paclitaxel (PTX, the hydrophobic small-molecule anti-cancer model drug) was achieved by the 400-nm PLGA (Mw: 7,000-17,000 g/mol, LA/GA: 50/50) particles with potential biopharmaceutical applications in cancer therapy.

Les études de libération de substance active à partir de système polymériques tels que des microparticules à base d’acide poly(lactique-co-glycolique) (PLGA) ont été largement explorées au cours de ces dernières décennies . L’objectif principal de ce travail consiste à mieux comprendre les mécanismes de transport de masse contrôlant la libération de substance active à partir des microparticules de PLGA. Un nouvel aperçu devait être acquis sur la base de suivi expérimental de la cinétique de gonflement de microparticules. Dans un premier temps, des microparticules à base de PLGA chargées de différents types de substances actives (acide, base et neutre), tels que kétoprofen, prilocaine base libre et dexamethasone ont été préparées par simple émulsion (huile dans eau) en utilisant une méthode d'extraction/évaporation du solvant. Les microparticules obtenues avaient des taux d’efficacité d’encapsulation qui sont variables selon la substance active utilisée. Une caractérisation des propriétés clés des microparticules obtenues a été réalisée en utilisant différentes techniques (microscopie optique, microscopie électronique). La chromatographie par permeation de gel a été utilisé pour déterminer le poids moléculaire du PLGA après exposition des microparticules au milieu de libération à différents temps afin d’évaluer la cinétique de dégradation du polymère. La diffraction des rayons X et la calorimétrie différentielle à balayage étaient utilisés pour étudier l’état physique du polymère, de la substance active pure ainsi que les microparticules chargées en substance active. Les études de libération ont montré deux types de profils de libération : un profil tri-phasique et un profil plus ou moins mono-phasique. Le profil tri-phasique observé est constitué de trois phases : une phase de libération initiale rapide suivie d’une libération constante qui est suivie ; à son tour ; par une seconde phase de libération rapide. En revanche, les différentes phases étaient difficilement distinguées pour le deuxième type de profil obtenu, du fait de la libération rapide de substance active ce qui permet de dire que les profils obtenus étaient plus ou moins mono-phasique. L’élucidation des mécanismes de libération de substance active était basée sur le suivi expérimental de la cinétique de gonflement des microparticules. Comme pour les cinétiques de libération obtenues à partir des microparticules à base de PLGA, différentes phases peuvent être distinguées pour les profils de gonflement. Les transitions d’une phase à une autre semblent s’accorder entre le profil de libération et celui du gonflement. Ainsi, le gonflement des microparticules pourrait contribuer au contrôle de la libération de la substance active à partir des microparticules à base de PLGA. / The drug release studies from polymeric system such as Poly(lactic-co-glycolic) acid (PLGA)-based microparticles have been widely investigated during recent decades. The main objective of this work is to better understand the mass transport mechanisms controlling the drug release kinetics from PLGA microparticles. New insight was to be gained based on the experimental monitoring of the swelling kinetics of single microparticle. Initially, PLGA microparticles containing different type of drugs (acidic, basic and neutral), such as ketoprofen, prilocaine free base and dexamethasone were prepared using simple oil in water emulsion extraction/evaporation solvent technique. The characterization of the key properties of microparticles was performed using different techniques (optical microscopy, electron microscopy). The gel permeation chromatography was used to determine the molecular weight of PLGA following exposure of microparticles to the release medium at various times to assess the kinetic degradation of the polymer. The X-ray diffraction and differential scanning calorimetry were used to study the physical state of the polymer, drug and drug-loaded microparticles. Release studies have shown two types of release profiles: tri-phasic and more or less mono-phasic profile. The tri-phasic profile is composed of three phases: an initial rapid release phase followed by a constant release which is followed by a second phase of rapid release. In contrast, at the investigated higher initial drug loadings, different release phases could hardly be distinguished: The profiles were more or less mono-phasic. The elucidation of drug release mechanisms was based on the experimental results of the swelling kinetics of single microparticles. As for drug release, distinct phases can be distinguished for microparticles swelling. The transition from one phase to another seem to coincide for microparticle swelling and drug release. Thus also microparticle swelling might contribute to a significant extent to the control of drug release.

L'objectif de cette thèse est de préparer des microsphères chargées en une protéine modèle, le lysozyme, en utilisant un nouveau copolymère pentabloc. La libération de protéine à partir des microsphères obtenues doit être continue et complète sur une période d’au moins un mois. Des copolymères pentabloc PLGA-P188-PLGA et une protéine modèle, le lysozyme, ont été utilisés. La présence du bloc central P188 la masse molaire du segment PLGA, le type de solvant, la concentration en polymère, la vitesse d’agitation de l’émulsion et la teneur en tensioactif ont tous un effet sur la porosité des microsphères. La teneur en tensioactif et la vitesse d'agitation ont principalement contribué au contrôle de la taille des particules. En ajustant les caractéristiques du segment PLGA et les paramètres du procédé, la libération de la protéine a été améliorée. Une libération prolongée et complète de protéines sur 8 semaines a été obtenue en suivant le modèle d’Higuchi. La modulation du profil de libération de la protéine a été obtenue par un mélange physique de différentes microsphères. Cette stratégie peut-être appliquée à une seule protéine ou dans le cadre d’une thérapie combinée. / The aim of this thesis is to formulate protein-loaded microspheres with penta-block copolymers for a sustained and completed protein release for at least one month. A new PLGA-P188-PLGA penta-block copolymers were used. The presence of a P188 central block facilitated the control of particle morphology and size. LA/GA ratio, the molecular weight of PLGA segment, solvent type, polymer concentration, emulsifying speed and surfactant content all affected microsphere porosity.The surfactant concentration and agitation speed principally contributed to particle size control. By adjusting the polymer characteristics and the process parameters, the protein release was improved remarkably. An 8-week completed and sustained protein release complying with the Higuchi model was achieved. The physical mixing of different microparticles was then studied for modulating release profile.The achievement of protein delivery with controlled release profile raised its applicability, especially for one protein sustained release or combined therapy.

Silicone release liners are silicone coatings on top of papers or films that are used in the adhesives industry to prevent adhesion before the final use of the adhesive e.g. labels. The process of production of release liners involves the casting of molten polysiloxanes on top of the substrates that crosslink by hydrosilylation reaction forming silicone networks. The quality of the release liner can be assessed by diverse methods usually performed when the coating process has been finished. Rarely an online control of the reaction is possible. Fluorescence spectroscopy was found to be a non-invasive useful method to control the reaction during the whole process by introducing very small concentration of fluorescent molecules in the polymer formulations; those fluorophores are sensitive to environmental changes as the silicone polymer molecules crosslink. In response to that stimulus, the fluorescence intensity varies along the time upon reaction allowing the identification of the gel point and further modifications or molecules rearrangements in a post-curing stage within weeks that are non-observable with conventional quality control methods. It was found that the fluorescent molecules do not require to be attached covalently to the polysiloxanes, thus fluorescence spectroscopy is a simple method to implement for controlling the production of silicone coatings. Moreover, the characterization of several silicone formulations was performed to find the optimal conditions for the production of release liners and to understand the effect of every component in the formulation on the performance of the silicones. The kinetics of the reaction was also studied and even a mechanism for the hydrosilylation reaction was proposed.

No description available.

Plants require N to complete their life cycle. Without adequate concentration of N, crops will not produce their potential yields. For turfgrass systems, N fertilizer application allows for the maintenance of functional, aesthetic, and recreational properties. However, fertilizer mismanagement is common and leads to N pollution in the environment. Controlled-release and slow-release fertilizers can enhance nitrogen (N)-use efficiency, reduce N pollution, minimize the need for repeated fertilizer applications, and reduce turfgrass shoot growth and associated costs. In order to evaluate the effectiveness of these fertilizers in the Intermountain West, research is needed. The timing of N release was evaluated for seven urea fertilizers: uncoated, sulfur coated (SCU), polymer-sulfur coated (PSCU), and four polymer-coated (PCU) with release timings of 45, 75, 120, and 180 d estimated release. These products were placed on bare soil, a Kentucky bluegrass (Poa pratensis L.) thatch layer, and incorporated into soil. These three placement treatments were replicated to allow for enough samples to be placed in two locations. The first was outside in a field to represent field conditions with diurnal fluctuating temperatures and the second was placed in a storage facility to replicate laboratory conditions with static diurnal temperatures. The PCU prills incorporated into soil under field conditions generally released N over the estimated release period. However, when applied to bare soil or thatch, N from PCU had 80% or greater N release by 35 d after application regardless of expected release time. Fertilizers under laboratory conditions had minimal N release despite having similar average daily temperatures, suggesting that fluctuating temperatures impact N release. The PSCU and SCU treatments were no different from uncoated urea, showing no slow release properties for this particular product. Spring-applied N fertilizer trials were conducted over two years to determine the optimal N rate for Kentucky bluegrass. Similar PCU120 products were applied at 50, 75, and 100% of the recommended full rate, while also being compared to an unfertilized control and urea applied either all at once or split monthly. Spring-applied PCU showed minimal initial N response while urea applied all at once resulted in an initial spike of N uptake. Once PCU began to release N, there was minimal difference for all rates compared to urea split monthly for biomass growth, verdure, and shoot tissue N. Although at the 50% rate, there were a few sampling dates with slower growth and lower verdure. The decrease in verdure at this low rate was slight, and it is recommended that PCU could be applied effectively at a reduced rate between 50 and 75%. Although for better results, additional quick release N is required to compensate for early season lag in N release.

A study was conducted to investigate and quantify the effects of corrosion inhibitors on metal release within a pilot distribution system while varying the source water. The pilot distribution system consisted of pre-existing facilities from Taylor et al (2005). Iron, copper, and lead release data were collected during four separate phases of operation. Each phase was characterized by the particular blend ratios used during the study. A blended source water represented a water that had been derived from a consistent proportion of three different source waters. These source waters included (1) surface water treated through enhanced coagulation/sedimentation/filtration, (2) conventionally treated groundwater, and (3) finished surface water treated using reverse osmosis membranes. The corrosion inhibitors used during the study were blended orthophosphate (BOP), orthophosphate (OP), zinc orthophosphate (ZOP), and sodium silicate (Si). This document was intended to cite the findings from the study associated with corrosion treatment using various doses of sodium silicate. The doses were maintained to 3, 6, and 12 mg/L as SiO2 above the blend-dependent background silica concentration. Sources of iron release within the pilot distribution system consisted of, in the following order of entry, (1) lined cast iron, (2) un-lined cast iron, and (3) galvanized steel. Iron release data from these materials was not collected for each individual iron source. Instead, iron release data represented the measurement of iron upon exposure to the pilot distribution system in general. There was little evidence to suggest that iron release was affected by sodium silicate. Statistical modeling of iron release suggested that iron release could be described by the water quality parameters of alkalinity, chlorides, and pH. The R2 statistic implied that the model could account for only 36% of the total variation within the iron release data set (i.e. R2 = 0.36). The model implies that increases in alkalinity and pH would be expected to decrease iron release on average, while an increase in chlorides would increase iron release. The surface composition of cast iron and galvanized steel coupons were analyzed using X-ray photoelectron spectroscopy (XPS). The surface analysis located binding energies consistent with Fe2O3, Fe3O4, and FeOOH for both cast iron and galvanized steel. Elemental scans detected the presence of silicon as amorphous silica; however, there was no significant difference between scans of coupons treated with sodium silicate and coupons simply exposed to the blended source water. The predominant form of zinc found on the galvanized steel coupons was ZnO. Thermodynamic modeling of the galvanized steel system suggested that zinc release was more appropriately described by Zn5(CO3)2(OH)6. The analysis of the copper release data set suggested that treatment with sodium silicate decreased copper release during the study. On average the low, medium, and high doses decreased copper release, when compared to the original blend source water prior to sodium silicate addition, by approximately 20%, 30%, and 50%, respectively. Statistical modeling found that alkalinity, chlorides, pH, and sodium silicate dose were significant variables (R2 = 0.68). The coefficients of the model implied that increases in pH and sodium silicate dose decreased copper release, while increases in alkalinity and chlorides increased copper release. XPS for copper coupons suggested that the scale composition consisted of Cu2O, CuO, and Cu(OH)2 for both the coupons treated with sodium silicate and those exposed to the blended source water. Analysis of the silicon elemental scan detected amorphous silica on 3/5 copper coupons exposed to sodium silicate. Silicon was not detected on any of the 8 control coupons. This suggested that sodium silicate inhibitor varied the surface composition of the copper scale. The XPS results seemed to be validated by the visual differences of the copper coupons exposed to sodium silicate. Copper coupons treated with sodium silicate developed a blue-green scale, while control coupons were reddish-brown. Thermodynamic modeling was unsuccessful in identifying a controlling solid that consisted of a silicate-based cupric solid. Lead release was generally decreased when treated with sodium silicate. Many of the observations were recorded below the detection limit (1 ppb as Pb) of the instrument used to measure the lead concentration of the samples during the study. The frequency of observations below the detection limit tended to increase as the dose of sodium silicate increased. An accurate quantification of the effect of sodium silicate was complicated by the observations recorded below detection limit. If the lead concentration of a sample was below detection limit, then the observation was recorded as 1 ppb. Statistical modeling suggested that temperature, alkalinity, chlorides, pH, and sodium silicate dose were important variables associated with lead release (R2 = 0.60). The exponents of the non-linear model implied that an increase in temperature, alkalinity, and chlorides increased lead release, while an increase in pH and sodium silicate dose were associated with a decrease in lead release. XPS surface characterization of lead coupons indicated the presence of PbO, PbO2, PbCO3, and Pb3(OH)2(CO3)2. XPS also found evidence of silicate scale formation. Thermodynamic modeling did not support the possibility of a silicate-based lead controlling solid. A solubility model assuming Pb3(OH)2(CO3)2 as the controlling solid was used to evaluate lead release data from samples in which lead coupons were incubated for long stagnation times. This thermodynamic model seemed to similarly describe the lead release of samples treated with sodium silicate and samples exposed to the blended source water. The pH of each sample was similar, thus sodium silicate, rather than the corresponding increase in pH, would appear to be responsible if a difference had been observed. During the overall study, the effects of BOP, OP, ZOP, and Si corrosion inhibitors were described by empirical models. Statistically, the model represented the expected value, or mean average, function. If these models are to be used to predict a dose for copper release, then the relationship between the expected value function and the 90th percentile must be approximated. The USEPA Lead and Copper Rule (LCR) regulates total copper release at an action level of 1.3 mg/L. This action level represents a 90th percentile rather than a mean average. Evaluation of the complete copper release data set suggested that the standard deviation was proportional to the mean average of a particular treatment. This relationship was estimated using a linear model. It was found that most of the copper data sub-sets (represented by a given phase, inhibitor, and dose) could be described by a normal distribution. The information obtained from the standard deviation analysis and the normality assumption validated the use of a z-score to relate the empirical models to the estimated 90th percentile observations. Since an analysis of the normality and variance (essentially contains the same information as the standard deviation) are required to assess the assumptions associated with an ANOVA, an ANOVA was performed to directly compare the effects of the inhibitors and corresponding doses. The findings suggested that phosphate-based inhibitors were consistently more effective than sodium silicate when comparing the same treatment levels (i.e. doses). Among the phosphate-based inhibitors, the effectiveness of each respective treatment level was inconsistent (i.e. there was no clear indication that any one phosphate-based inhibitor was more effective than the other). As the doses increased for each inhibitor, the results generally suggested that there was a corresponding tendency for copper release to decrease.

This research is the first systematic investigation of solid-state orientation as a novel method for controlling drug release from biodegradable polymers. The effect of various degrees of polymer orientation was studied in oriented Poly (L-lactic acid) (PLA) films containing curcumin and theophylline as model drugs. Additionally, direction specific drug release was studied from oriented PLA rods containing paracetamol. The films oriented to 2X uniaxial constant width (UCW) or 2X2Y biaxial draw ratio showed retardation of drug release, when their nematic structure was stabilised by the presence of crystalline theophylline. Contrarily, the same films when contained solid solution of curcumin, shrunk in the release medium and exhibited a release profile similar to the un-oriented films. All films oriented to the UCW draw ratio ≥ 3X contained α crystalline form of PLA and showed acceleration of drug release proportionate to the draw ratio. According to the proposed mechanism augmented formation of water filled channels in these films was responsible for faster drug release. Similarly, the paracetamol loaded PLA rods die-drawn to uniaxial draw ratios ≥ 3X exhibited enhancement of drug release. Importantly, the amount of drug released along the oriented chain axis was significantly larger than that in the perpendicular direction. Drug release from the die-drawn rods was accelerated by a greater degree than that observed from the oriented films. This can be correlated to the differences in their size, geometry and the crystalline form of PLA. In conclusion, the current study provided substantial evidence that solid-state orientation can offer a control over drug release from PLA.

<p dir="ltr">Opioid use disorder (OUD) presents a challenging and nuanced condition with potential for debilitating social and physical consequences. Patients with OUD have access to treatment options, but they may encounter issues such as diversion, invasiveness, or poor adherence. With over 2.5 million adults in the US experiencing OUD as of 2021, the need for an OUD treatment that overcomes these challenges is clear. One available treatment method is Sublocade®, a PLGA-based in situ forming implant (ISFI) that releases buprenorphine. This treatment shows promise due to its physician administered extended release design, which addresses many current issues in OUD treatment. However, the practicality of this treatment remains a challenge due to its monthly injection requirement. To address this, we investigated how altering ISFI components impacts the timeframe of buprenorphine release from a PLGA-based ISFI. Our focus was on evaluating factors that lead to extended buprenorphine release while maintaining zero-order release. We varied polymer-to-solvent ratios, drug percentage, and solvent composition, assessing their effects through drug release studies. We also conducted SEM imaging and swelling/erosion studies to evaluate polymer behavior and implant microstructure, gaining further insights into drug release mechanisms. Our drug release studies revealed that higher buprenorphine content in the implant significantly reduced total drug release and linearized drug release patterns. Decreasing the polymer-to-solvent ratio similarly linearized drug release and reduced drug burst, although the overall amount of drug released over time remained similar. Introducing Triacetin (TA) as a solvent helped reduce drug burst and maintain release linearity in lower drug content implants. In higher drug content implants, TA appeared to increase drug release over time, likely due to degradation processes indicated by high swelling and increased degradation observed in SEM imaging. Erosion studies showed less implant erosion with higher drug loading, aligning with release study observations. In conclusion, solvent type and drug content significantly influence buprenorphine release in ISFI systems and should be carefully considered when designing extended release systems similar to Sublocade®.</p>